23andMe Holding Co. Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018
Net Income	-311.66	-217.49	-183.62	-250.86	-183.53
Depreciation & Amortization	36.5	26.15	20.25	23.29	9.9
Share-Based Compensation	116.02	57.93	88.43	44.84	37.49
Other Operating Activities	-6.25	-33.42	0.7	-3.03	38.02
Operating Cash Flow	-165.39	-166.83	-74.25	-185.77	-98.12
Capital Expenditures	-11.31	-8.47	-6.54	-72.82	-27.84
Acquisitions	0	-94.17	0	0	0
Other Investing Activities	-	-5.5	-	-	-
Investing Cash Flow	-11.31	-108.14	-6.54	-72.82	-27.84
Share Issuance / Repurchase	10.67	576.65	76.15	8.83	72.16
Other Financing Activities	-0.89	-30.64	79.18	-	272.29
Financing Cash Flow	9.78	546	155.34	8.83	344.45
Exchange Rate Effect	0.39	-0.15	0	0	0
Net Cash Flow	-166.53	270.89	74.55	-249.76	218.49
Free Cash Flow	-176.7	-175.3	-80.79	-258.59	-125.96
Free Cash Flow Margin	-59.00%	-64.47%	-33.12%	-84.65%	-28.57%
Free Cash Flow Per Share	-0.39	-0.48	-0.81	-2.93	-3.65

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).